-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Ardent Health, Raises Price Target to $13.5

Benzinga·05/07/2026 22:38:34
Listen to the news
UBS analyst A.J. Rice maintains Ardent Health (NYSE:ARDT) with a Buy and raises the price target from $13 to $13.5.